✦ LIBER ✦

Prevention and treatment of CMV infection after allogeneic bone marrow transplant

✍ Scribed by E. Gluckman; R. Traineau; A. Devergie; H. Esperou-Bourdeau; I. Hirsch

Publisher: Springer
Year: 1992
Tongue: English
Weight: 369 KB
Volume: 64
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf01715372

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of viral infections after bon

Prevention of viral infections after bone marrow transplantation

✍ U. Schuler; G. Ehninger 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 727 KB

Treatment of hematological malignancies

Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation

✍ J.-M. Boiren; P. Cony-Makhoul; A. Pigneux; M. Puntous; J. Reiffers; J.-M. Boiron 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 903 KB

Cytomegalovirus (CMV) infections in pati

Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation

✍ Schmeiser, Th. ;Heit, W. ;Arnold, R. ;Bunjes, D. ;Wiesneth, M. ;Hertenstein, B. 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 939 KB

Treatment and prevention of bone marrow

Treatment and prevention of bone marrow transplant nephropathy

✍ John E. Moulder; Eric P. Cohen; Patricia Hill; Brian L. Fish 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Functions of granulocytes after allogene

Functions of granulocytes after allogeneic bone marrow transplantation

✍ Broek, P. J. ;Meer, J. W. M. ;Leijh, P. C. J. ;Zwaan, F. ;Barselaar, M. ;Furth, 📂 Article 📅 1981 🏛 Springer-Verlag ⚖ 249 KB

Incidence and prognosis of cytomegalovir

Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation

✍ Dr. D. Guyotat; R. Gibert; J. Chomel; E. Archimbaud; S. Bossard; J. Maupas; D. F 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

The incidence and the outcome of cytomegalovirus (CMV) infections were evaluated in 83 adult recipients of allogenic bone marrow transplantation. Virological and serological surveillance was performed weekly for 3 months posttransplant, and then every other week or every month until 1 year. CMV infe